PrEP For Teens and Young Adults: Are You Doing Your Part to Prevent HIV in Your Patients?

Overview

Launch date: 11/18/2023
Expiration date:11/18/2024

Provider Statement

This activity is provided by Global Education Group. (ACCME Credit)
This activity is jointly provided by Global Education Group and Integritas Communications. (AANP Credit)

Support Statement

This activity is supported by an educational grant from Gilead Sciences, Inc.

Target Audience

The educational design of this activity addresses the needs of pediatric MDs, NPs, PAs, and nurse specialists—as well as fellows, residents, residency directors, and physician educators.

Program Description

This Interactive Professor™ session is designed to educate clinicians in pediatric settings in assessing patients for risk of HIV acquisition, and in selecting, initiating, and conducting ongoing monitoring of preexposure prophylaxis (PrEP) regimens to prevent HIV.

Educational Objectives

After completing this activity, the participant should be better able to:

• Demonstrate an understanding of HIV epidemiology among teens and young adults in the United States
• Incorporate HIV risk and PrEP eligibility assessment for all sexually active patients in the pediatric setting
• Describe key components of PrEP initiation and management for the adolescent/young adult population

Faculty

Renata Sanders, MD, MPH, ScM
Chief, Craig-Dalsimer Division of Adolescent Medicine
Orton Jackson Endowed Chair in Adolescent Medicine
The Children's Hospital of Philadelphia
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Dr. Sanders is the incoming Chief of the Craig-Dalsimer Division of Adolescent Medicine and Orton Jackson Endowed Chair in Adolescent Medicine at The Children's Hospital of Philadelphia; Professor of Pediatrics, PAR, at Perelman School of Medicine of the University of Pennsylvania. Her expertise includes adolescent sexually transmitted infection(s) and HIV, caring for lesbian, gay, bisexual, transgender, and questioning youth, and transition to adult care. She has had a joint appointment in Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health’s Departments of Epidemiology and Health, Behavior and Society in Baltimore, Maryland. For the last 6 years, she has served as the Director of Pediatric & Adolescent Services, Johns Hopkins Children’s Center Services for Transgender & Gender Expansive Health, Medical Director of the Pediatric and Adolescent HIV/AIDS Program, Director of the PrEP Program, co-Founder/co-Director of the Emerge Gender and Sexuality Clinic, and the co-Director of the Adolescent and Young Adult Scientific Working Group, Johns Hopkins Center for AIDS Research. She currently serves on the International AIDS Society Governing Council, Scholarship Program, Stigma Advisory Board, and Abstract Review Committees; Collaborative Initiative for Paediatric HIV Education and Research; the Research Review Committee of the American Board of Pediatrics, and Board of Directors of SIECUS (Sexual Information and Education Council of the United States), Sex Ed for Social Change, and American Sexual Health Association.

Program Agenda

• HIV burden among adolescents and young adults in the United States
• Discussing sexual health without stigma or judgment
• What is PrEP?
• Selecting, initiating, and monitoring PrEP regimens

Physician Accreditation Statementt

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates this enduring materials for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education
The activity has been planned and implemented in
accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Integritas Communications. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 0.5 contact hour (which includes 0.1 hour(s) of pharmacology).

Global Contact Information

For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

To receive credit for this activity, participants must review the material, achieve 70% or higher on the posttest, and complete the evaluation.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Relevant Financial Relationships

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

The planners and managers at Global Education Group and Integritas Communications have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.